FindMyKOL
Clinical trialNCT06872190RecruitingInterventional

Using Clinical Decision Support to Provide Social Risk-Informed Care for Opioid Use Disorder in the Emergency Department

NCT06872190 is an interventional trial sponsored by University of California, San Francisco. As of 21 Nov 2026, it is recruiting participants. It studies Opioid Use Disorder and Social Determinants of Health (SDOH). The registry lists an enrollment of 300 participants at 1 site in 1 country. The registry lists a start date of 20 Apr 2025 and a primary completion date of 31 Jul 2027.

SponsorUniversity of California, San Francisco →Enrollment300Opioid Use DisorderSocial Determinants of Health (SDOH)
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT06872190
FieldValue
Registry IDNCT06872190
StatusRecruiting
Study typeInterventional trial
Lead sponsorUniversity of California, San Francisco
Enrollment300
Registered sites1
Countries1
ConditionsOpioid Use Disorder and Social Determinants of Health (SDOH)
Start20 Apr 2025
Primary completion31 Jul 2027
Study completion31 Jul 2027
Last update posted29 Jun 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The overarching goal of this proposal is to integrate patient social risk information into an existing electronic health record (EHR)-based clinical decision support (CDS) tool (CDSv1) to facilitate emergency department (ED)-initiated, social risk-informed opioid use disorder (OUD) medication treatment and ultimately improve treatment adherence and follow up. The investigators will evaluate the feasibility and acceptability of the social care-enhanced CDS tool, CDSv2, (compared to CDSv1) at a single study site (UCSF) as an intervention to increase medication treatment adherence and follow up for adult ED patients experiencing opioid use disorder using a mixed-methods, before-after approach.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States1 site, 1 recruiting
  • University of California, San Francisco

    San Francisco

    Recruiting

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 1 site, 1 recruitingCA1NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT06872190

Each answer restates registry values shown on this page.

What is NCT06872190?

NCT06872190 is an interventional trial sponsored by University of California, San Francisco. It studies Opioid Use Disorder and Social Determinants of Health (SDOH).

Is NCT06872190 recruiting?

As of 21 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.

Who leads NCT06872190?

The registry names Melanie F Molina, MD, MAS (principal investigator, University of California, San Francisco) as the overall official.

Where does NCT06872190 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT06872190 expected to complete?

The registry lists a primary completion date of 31 Jul 2027 and a study completion date of 31 Jul 2027. The sponsor last updated the record on 29 Jun 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.